HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,933,492 | +71.4% | 77,400 | +62.9% | 0.74% | +49.9% |
| Q2 2023 | $4,044,150 | +32.4% | 47,500 | +28.7% | 0.49% | +3.6% |
| Q1 2023 | $3,053,475 | +97.1% | 36,900 | +87.3% | 0.47% | +44.1% |
| Q4 2022 | $1,549,405 | -61.8% | 19,700 | -51.4% | 0.33% | -63.7% |
| Q4 2018 | $4,056,000 | -33.1% | 40,535 | -23.4% | 0.91% | -22.8% |
| Q3 2018 | $6,061,000 | +96.3% | 52,900 | +53.7% | 1.18% | +51.4% |
| Q2 2018 | $3,087,000 | – | 34,420 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |